Synthetic erythropoietic proteins: Tuning biological performance by site-specific polymer attachment

被引:35
作者
Chen, SY
Cressman, S
Mao, F
Shao, H
Low, DW
Beilan, HS
Cagle, EN
Carnevali, M
Gueriguian, V
Keogh, PJ
Porter, H
Stratton, SM
Wiedeke, MC
Savatski, L
Adamson, JW
Bozzini, CE
Kung, A
Kent, SBH
Bradburne, JA
Kochendoerfer, GG
机构
[1] Gryphon Therapeut, San Francisco, CA 94080 USA
[2] Blood Ctr SE Wisconsin Inc, Blood Res Inst, Milwaukee, WI 53226 USA
[3] Univ Buenos Aires, Catedra Fisiol, Fac Odontol, RA-1122 Buenos Aires, DF, Argentina
来源
CHEMISTRY & BIOLOGY | 2005年 / 12卷 / 03期
关键词
D O I
10.1016/j.chembiol.2005.01.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemical synthesis in combination with precision polymer modification allows the systematic exploration of the effect of protein properties, such as charge and hydrodynamic radius, on potency using defined, homogeneous conjugates. A series of polymer-modified synthetic erythropoiesis proteins were constructed that had a polypeptide chain similar to the amino acid sequence of human erythropoietin but differed significantly in the number and type of attached polymers. The analogs differed in charge from +5 to -26 at neutral pH and varied in molecular weight from 30 to 54 kDa. All were active in an in vitro cell proliferation assay. However, in vivo potency was found to be strongly dependent on overall charge and size. The trends observed in this study may serve as starting points for the construction of more potent synthetic EPO analogs in the future.
引用
收藏
页码:371 / 383
页数:13
相关论文
共 40 条
[1]  
ALIPPI RM, 1983, EXP HEMATOL, V11, P122
[2]   Rational design of a potent, long-lasting form of interferon:: A 40 kDa branched polyethylene glycol-conjugated interferon α-2a for the treatment of hepatitis C [J].
Bailon, P ;
Palleroni, A ;
Schaffer, CA ;
Spence, CL ;
Fung, WJ ;
Porter, JE ;
Ehrlich, GK ;
Pan, W ;
Xu, ZX ;
Modi, MW ;
Farid, A ;
Berthold, W .
BIOCONJUGATE CHEMISTRY, 2001, 12 (02) :195-202
[3]   Native chemical ligation using removable Nα-(1-phenyl-2-mercaptoethyl) auxiliaries [J].
Botti, P ;
Carrasco, MR ;
Kent, SBH .
TETRAHEDRON LETTERS, 2001, 42 (10) :1831-1833
[4]   TOTAL CHEMICAL SYNTHESIS OF A UNIQUE TRANSCRIPTION FACTOR-RELATED PROTEIN - CMYC-MAX [J].
CANNE, LE ;
FERREDAMARE, AR ;
BURLEY, SK ;
KENT, SBH .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (11) :2998-3007
[5]   Glycosylation of erythropoietin affects receptor binding kinetics: Role of electrostatic interactions [J].
Darling, RJ ;
Kuchibhotla, U ;
Glaesner, W ;
Micanovic, R ;
Witcher, DR ;
Beals, JM .
BIOCHEMISTRY, 2002, 41 (49) :14524-14531
[6]   CHARACTERIZATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN PRODUCED IN CHINESE-HAMSTER OVARY CELLS [J].
DAVIS, JM ;
ARAKAWA, T ;
STRICKLAND, TW ;
YPHANTIS, DA .
BIOCHEMISTRY, 1987, 26 (09) :2633-2638
[7]   SYNTHESIS OF PROTEINS BY NATIVE CHEMICAL LIGATION [J].
DAWSON, PE ;
MUIR, TW ;
CLARKLEWIS, I ;
KENT, SBH .
SCIENCE, 1994, 266 (5186) :776-779
[8]   Synthesis of native proteins by chemical ligation [J].
Dawson, PE ;
Kent, SBH .
ANNUAL REVIEW OF BIOCHEMISTRY, 2000, 69 :923-960
[9]   Development and characterization of novel erythropoiesis stimulating protein (NESP) [J].
Egrie, JC ;
Browne, JK .
BRITISH JOURNAL OF CANCER, 2001, 84 (Suppl 1) :3-10
[10]  
GOSDEN A, 1972, CHEM COMMUN, V8, P1123